In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Showing 1 to 26 of 26

TitleConsultationTypeConsultation end date
Polyendocrine Metabolic Ovarian Syndrome (PMOS)Draft guidanceNICE guideline
Bladder cancer: diagnosis and management (update)ScopingNICE guideline
Pembrolizumab with chemotherapy for adjuvant treatment of newly diagnosed high-risk endometrial cancer after surgery with curative intent [ID6207]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Catumaxomab for intraperitoneal treatment of malignant ascites caused by EpCAM-positive carcinomas when further systemic anticancer treatment is unsuitable [ID6580]Draft guidanceTechnology appraisal guidance
In-situ abdominal normothermic regional perfusion to preserve donor livers during retrieval for transplantation after controlled circulatory deathInterventional procedure consultationHealthTech guidance
Technologies for diagnosing endometriosis in primary care: early use assessmentDraft guidanceHealthTech guidance
Middle meningeal artery embolisation for non-acute subdural haematomasInterventional procedure consultationHealthTech guidance
Digital platforms to support preparation before and rehabilitation after primary elective hip or knee replacement surgery: early-use assessmentDraft guidanceHealthTech guidance
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (MA review of TA781) [ID6287]Final draft guidanceTechnology appraisal guidance
Secukinumab for treating relapsed polymyalgia rheumatica ID6599Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Ibrutinib with R-CHOP for untreated mantle cell lymphoma when an autologous stem cell transplant is suitable [ID6596]Draft guidanceTechnology appraisal guidance
Headaches (update): Prophylactic treatment of migraine - CandesartanDraft scope consultationNICE guideline
Beremagene geperpavec for treating skin wounds associated with dystrophic epidermolysis bullosa [ID3959]Draft guidanceTechnology appraisal guidance
Suspected sepsis: recognition, diagnosis and early management - procalcitonin testingDraft guidance consultationNICE guideline
Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID6575]Final draft guidanceTechnology appraisal guidance
Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liverInterventional procedure consultationHealthTech guidance
Blood-based biomarker tests for surveillance in people at risk of hepatocellular carcinomaDraft scope consultationHealthTech guidance
Digital technologies to support home monitoring of vision changes for people with advanced dry age-related macular degeneration: early-use assessmentDraft guidanceHealthTech guidance
Digital technologies to aid the scoring and interpretation of diagnostic sleep studies for obstructive sleep apnoea and rare sleep disordersDraft scope consultationHealthTech guidance
Topical tapinarof for treating atopic dermatitis in people 2 years and over ID6713Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Topical tapinarof for treating mild to severe plaque psoriasis ID6712Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Software with artificial intelligence (AI)-derived algorithms to help interpret electroencephalograms (EEGs) for suspected epilepsy: early-use assessmentDraft guidanceHealthTech guidance
Resmetirom for treating non-alcoholic steatohepatitis and liver fibrosis [ID6529]Draft guidanceTechnology appraisal guidance
Teclistamab for treating relapsed or refractory multiple myeloma after 1 or more treatments ID6628Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Mezigdomide with dexamethasone and carfilzomib for treating relapsed or refractory multiple myeloma after at least 1 line of treatment ID6513Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Renal sympathetic denervation for resistant hypertensionDraft scope consultationHealthTech guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All